People with diabetes have a higher chance of getting tuberculosis (TB) and worldwide diabetes is now responsible for >10% of the tuberculosis epidemic. People with diabetes have a more than 3-fold increased risk of developing tuberculosis. Diabetes is also associated with more severe tuberculosis, and more deaths and failing treatment. More than 400 million people worldwide have diabetes and this number is increasing rapidly, especially in countries where TB is endemic.Relatively little is known about the effects of diabetes on TB in Africa.
Reinout van Crevel and Lindsey te Brake have received European funding (4,8 million euros) to lead an international consortium to screen thousands of people with diabetes in Uganda and Tanzania for TB, and investigate the effect and costs of 3 months preventive treatment for TB.
Tuberculosis affects> 10 million people annually and more than 1 million people die from the disease. Moreover, an estimated one quarter of the world's population is infected with Mycobacterium tuberculosis and they have a lifelong risk of getting active tuberculosis.
It is impossible to reduce tuberculosis without paying attention to the large group with "latent tuberculosis infection". High-risk groups such as small children and HIV-infected people are therefore already being treated preventively. People with diabetes could be a logical next group, but this has not yet been investigated.
In recent years, Reinout van Crevel has led a major international initiative "TANDEM" (which stands for "tuberculosis and diabetes mellitus") with a combination of clinical studies in Africa, Peru, Romania and Indonesia, and laboratory research in Radboudumc and other laboratories. TANDEM has provided many new insights, for example with regard to the greatly increased risk of tuberculosis with the combination of diabetes and latent tuberculosis. And now the work of TANDEM can be continued with this large - and first - clinical trial to investigate preventive treatment for TB in people with diabetes, including looking at screening, costs, quality of care and epidemiological effects of diabetes on TB in Africa.
Reinout van Crevel and Lindsey te Brake are members of theme Infectious diseases and global health.
Related news items
KWF Roadshow 11 November 201910 October 2019
In which way(s) can KWF provide optimal support to oncological research and care? How can we maximize impact on our investments? These questions are pivotal in Ambition 2030: the vision that KWF developed in close cooperation with stakeholders in the oncological field.read more
A personal touch of Frank Wagener10 October 2019
In order to promote interaction amongst colleagues within RIMLS, we have a ‘personal touch’ series setting employees in the spotlight. A light-hearted manner to learn about the colleagues you know and those you don’t. This week: Frank Wagener.read more
More than 3000 visitors at Open Day RIHS10 October 2019
On Sunday 6 October RIHS organized an Open Day in the Weekend of Science (“Weekend van de Wetenschap”) with special guest and television presenter Klaas van Kruistum. More than 3000 visitors became a health scientist for one day and discovered how special healthcare research is.read more
Dorine Swinkels collaborates with winners of the Nobel Prize in Physiology or Medicine9 October 2019
The Nobel Prize in Physiology or Medicine 2019 was awarded jointly to William G. Kaelin Jr, Sir Peter J. Ratcliffe and Gregg L. Semenza for their discoveries of how cells sense and adapt to oxygen availability.read more
Scaling up nanotherapy7 October 2019
Scaling up and translating nanotherapy from pre-clinical work in small animal models to a clinical application is not trivial. Raphael Duivenvoorden, theme Renal disorders, and colleagues, published their results on translating a new nanoimmunotherapy in the journal Science Translational Medicine.read more